{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000345.4:c.91G>C",
          "cDNA Change": {
            "transcript": "NM_000345.4",
            "ref": "G",
            "alt": "C",
            "position": "91"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "P",
            "position": "31"
          },
          "Description in input context": "A30P"
        },
        {
          "HGVS": "NM_000345.4:c.157G>A",
          "cDNA Change": {
            "transcript": "NM_000345.4",
            "ref": "G",
            "alt": "A",
            "position": "157"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "A53T"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005368"
  },
  "Experiment Method": [
    {
      "Assay Method": "Enzyme Activity Assay",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "Sf9 cells",
        "Description": "The experiment was conducted using Sf9 insect cells expressing human PLD2."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000345.4:c.91G>C",
          "Conclusion": "Normal",
          "Molecular Effect": "No Effect",
          "Result Description": "The A30P mutant did not differ significantly from wild-type in its capacity to inhibit PLD2."
        },
        {
          "Variant": "NM_000345.4:c.157G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Gain-of-function",
          "Result Description": "The A53T mutant displayed enhanced inhibition of PLD2 as compared to wild-type hAS."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Multiple experiments were performed with different batches of cells."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in multiple trials."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type cDNA was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "General Linear Model (GLM) to perform analysis of covariates (ANCOVA)"
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "PLD2 inhibition within a range of 20% to 40%.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "PLD2 inhibition greater than 50%.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}